• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 18, 2024

    3/18/24 5:57:15 AM ET
    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACXP alert in real time by email

    Companies Reporting Before The Bell

    • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

    • System1 (NYSE:SST) is estimated to report quarterly loss at $0.33 per share on revenue of $93.81 million.

    • Embraer (NYSE:ERJ) is estimated to report quarterly earnings at $0.53 per share on revenue of $2.00 billion.

    • Nano Labs (NASDAQ:NA) is estimated to report earnings for its Fiscal Year 2023.

    • Coda Octopus Group (NASDAQ:CODA) is likely to report quarterly earnings at $0.01 per share on revenue of $3.99 million.

    • Exagen (NASDAQ:XGN) is likely to report quarterly loss at $0.43 per share on revenue of $11.56 million.

    • Science Applications Intl (NASDAQ:SAIC) is likely to report quarterly earnings at $1.43 per share on revenue of $1.64 billion.

    • OneConnect Financial Tech (NYSE:OCFT) is projected to report quarterly loss at $1.62 per share on revenue of $142.69 million.

    • Acurx Pharmaceuticals (NASDAQ:ACXP) is likely to report earnings for its fourth quarter.

    Companies Reporting After The Bell

    • Red Cat Hldgs (NASDAQ:RCAT) is expected to report quarterly loss at $0.04 per share on revenue of $5.80 million.

    • Comtech Telecom (NASDAQ:CMTL) is estimated to report quarterly earnings at $0.22 per share on revenue of $152.85 million.

    • Bit Digital (NASDAQ:BTBT) is projected to report quarterly loss at $0.05 per share on revenue of $13.18 million.

    • FinVolution Gr (NYSE:FINV) is expected to report earnings for its fourth quarter.

    • StoneCo (NASDAQ:STNE) is projected to report quarterly earnings at $0.30 per share on revenue of $685.73 million.

    • National CineMedia (NASDAQ:NCMI) is likely to report quarterly earnings at $0.09 per share on revenue of $81.10 million.

    • Singular Genomics Sys (NASDAQ:OMIC) is estimated to report quarterly loss at $0.34 per share on revenue of $730 thousand.

    • Zepp Health (NYSE:ZEPP) is estimated to report quarterly earnings at $0.04 per share on revenue of $94.03 million.

    • Peraso (NASDAQ:PRSO) is estimated to report quarterly loss at $3.76 per share on revenue of $1.70 million.

    • Eyenovia (NASDAQ:EYEN) is projected to report quarterly loss at $0.17 per share on revenue of $130 thousand.

    • Lantern Pharma (NASDAQ:LTRN) is expected to report earnings for its fourth quarter.

    • Augmedix (NASDAQ:AUGX) is projected to report quarterly loss at $0.10 per share on revenue of $12.46 million.

    • Alpine Immune Sciences (NASDAQ:ALPN) is estimated to report quarterly loss at $0.34 per share on revenue of $9.10 million.

    • DLocal (NASDAQ:DLO) is likely to report quarterly earnings at $0.15 per share on revenue of $173.69 million.

    • JOYY (NASDAQ:YY) is estimated to report quarterly earnings at $0.77 per share on revenue of $558.30 million.

    • FreightCar America (NASDAQ:RAIL) is estimated to report quarterly loss at $0.01 per share on revenue of $135.00 million.

    • RF Industries (NASDAQ:RFIL) is estimated to report quarterly loss at $0.06 per share on revenue of $14.49 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACXP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACXP
    $ALPN
    $AUGX
    $BTBT

    CompanyDatePrice TargetRatingAnalyst
    StoneCo Ltd.
    $STNE
    2/9/2026$22.00Buy
    BTIG Research
    DLocal Limited
    $DLO
    12/17/2025$21.00Outperform
    Itau BBA
    Science Applications International Corporation
    $SAIC
    12/12/2025$122.00Buy
    Citigroup
    DLocal Limited
    $DLO
    12/11/2025$16.00Hold → Buy
    Truist
    National CineMedia Inc.
    $NCMI
    10/31/2025$7.00 → $6.50Outperform
    Barrington Research
    DLocal Limited
    $DLO
    10/14/2025$19.00Neutral → Buy
    Goldman
    Red Cat Holdings Inc.
    $RCAT
    10/3/2025$17.00Buy
    Needham
    Exagen Inc.
    $XGN
    9/11/2025$15.00Buy
    B. Riley Securities
    More analyst ratings

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Sullivan James

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:50 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Executive Officer Glibbery Ronald

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:37 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Operating Officer Lynch Brad

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:25 PM ET
    $PRSO
    Semiconductors
    Technology

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    SEC Filings

    View All

    SEC Form 424B3 filed by Acurx Pharmaceuticals Inc.

    424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)

    2/11/26 4:21:38 PM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Science Applications International Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Science Applications International Corp (0001571123) (Filer)

    2/11/26 6:55:57 AM ET
    $SAIC
    EDP Services
    Technology

    SEC Form SCHEDULE 13G filed by Red Cat Holdings Inc.

    SCHEDULE 13G - Red Cat Holdings, Inc. (0000748268) (Subject)

    2/9/26 8:00:04 AM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP,-Air Force & Comb Commands Difronzo Vincent P. received a gift of 2,452 shares, gifted 2,452 shares and bought $15,434 worth of shares (150 units at $102.89), decreasing direct ownership by 36% to 4,276 units (SEC Form 4)

    4 - Science Applications International Corp (0001571123) (Issuer)

    1/6/26 4:00:17 PM ET
    $SAIC
    EDP Services
    Technology

    EVP, Civilian Attili Srinivas bought $10,126 worth of shares (100 units at $101.26), increasing direct ownership by 0.74% to 13,635 units (SEC Form 4)

    4 - Science Applications International Corp (0001571123) (Issuer)

    1/2/26 4:13:46 PM ET
    $SAIC
    EDP Services
    Technology

    EVP General Counsel, Secretary Hageman Hilary bought $10,021 worth of shares (100 units at $100.21), increasing direct ownership by 0.53% to 19,006 units (SEC Form 4)

    4 - Science Applications International Corp (0001571123) (Issuer)

    12/17/25 4:01:55 PM ET
    $SAIC
    EDP Services
    Technology

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on StoneCo with a new price target

    BTIG Research initiated coverage of StoneCo with a rating of Buy and set a new price target of $22.00

    2/9/26 7:01:42 AM ET
    $STNE
    EDP Services
    Technology

    Itau BBA initiated coverage on dLocal Limited with a new price target

    Itau BBA initiated coverage of dLocal Limited with a rating of Outperform and set a new price target of $21.00

    12/17/25 9:18:01 AM ET
    $DLO
    Real Estate

    Citigroup initiated coverage on Science Applications with a new price target

    Citigroup initiated coverage of Science Applications with a rating of Buy and set a new price target of $122.00

    12/12/25 8:55:38 AM ET
    $SAIC
    EDP Services
    Technology

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    SAIC Announces Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2026 Financial Results and Updated Fiscal Year 2027 Guidance

    RESTON, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence and civilian agencies, today announced unaudited preliminary financial results for the fiscal fourth quarter and full fiscal year 2026 and updated its financial guidance for fiscal year 2027. The Company's announcement of unaudited preliminary financial results and updated guidance was primarily due to recent procurement delays and unfavorable customer award decisions. These items will result in a reduction to expected fiscal year 2026 and 2027 revenue compared to prior guidance. "While recent dynamics pressure our nea

    2/11/26 7:01:00 AM ET
    $SAIC
    EDP Services
    Technology

    Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026

    Lantern Pharma Inc. (NASDAQ:LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, today announced that CEO and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, February 17–19, 2026, in Boston, MA. More information about the summit is available at: https://glioblastoma-drugdevelopment.com. Lantern's proprietary AI and machine learning platform, RADR®, powered the development of LP-184 / STAR-001, a novel brain-penetrant therapeutic candidate. This work has driven the creation of Lantern's wholly owned subsidiary, Starlight Therapeutics, which is advancing clinical dev

    2/10/26 8:45:00 AM ET
    $LTRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MYDCOMBI issued to EYENOVIA INC.

    Submission status for EYENOVIA INC.'s drug MYDCOMBI (ORIG-1) with active ingredient TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE has changed to 'Approval' on 05/05/2023. Application Category: NDA, Application Number: 215352, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/8/23 1:05:04 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Leadership Updates

    Live Leadership Updates

    View All

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    StoneCo Announces New CEO, Reinforcing Continuity and Execution

    George Town, Grand Cayman--(Newsfile Corp. - January 7, 2026) - StoneCo Ltd. (NASDAQ:STNE) ("Stone" or "the Company") announces today that Mr. Pedro Zinner has informed the Board of Directors of his decision to resign from his position as Chief Executive Officer, effective March 2026, for personal reasons.Mr. Zinner assumed the role of CEO three years ago, following his service on the Company's Board, at a critical moment in Stone's trajectory. During his tenure, Stone executed a clear strategic pivot, including the divestment of non-core assets such as Linx, the implementation of broad streamlining initiatives, the establishment of a disciplined capital allocation framework, and meaningful

    1/7/26 7:10:00 AM ET
    $STNE
    EDP Services
    Technology

    Nano Labs Announces Results of Annual General Meeting of Shareholders

    HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (NASDAQ:NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider, today announced the results of the Company's Annual General Meeting ("AGM") held at 10 A.M. on December 30, 2025, Beijing time (9 P.M., December 29, 2025, U.S. Eastern time). The proposals submitted for shareholder approval at the AGM have been approved. Specifically, the shareholders have passed the following resolutions: 1)  to authorize (a) a share consolidation of every ten shares with a par value of US$0.002 each in the Company's issued and unissued share capital into one share with a par value of US$0.02 (the "Sh

    12/30/25 8:00:00 AM ET
    $NA
    Semiconductors
    Technology

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Financials

    Live finance-specific insights

    View All

    SAIC Announces Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2026 Financial Results and Updated Fiscal Year 2027 Guidance

    RESTON, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence and civilian agencies, today announced unaudited preliminary financial results for the fiscal fourth quarter and full fiscal year 2026 and updated its financial guidance for fiscal year 2027. The Company's announcement of unaudited preliminary financial results and updated guidance was primarily due to recent procurement delays and unfavorable customer award decisions. These items will result in a reduction to expected fiscal year 2026 and 2027 revenue compared to prior guidance. "While recent dynamics pressure our nea

    2/11/26 7:01:00 AM ET
    $SAIC
    EDP Services
    Technology

    Niu Technologies to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

    BEIJING, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU" or "the Company") (NASDAQ:NIU), the world's leading provider of smart urban mobility solutions, today announced that it will report its financial results for the fourth quarter and full year 2025 before the U.S. market opens on Monday, March 16, 2026. The corporate presentation and financial spreadsheets will be posted on NIU's investor relations website at: https://ir.niu.com/financial-information/quarterly-results The Company will host an earnings conference call on Monday, March 16, 2026 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) to discuss the financial and business results. To join via phone, part

    2/10/26 4:00:00 AM ET
    $NIU
    Auto Manufacturing
    Industrials

    Coda Octopus Group Reports Fiscal 2025 Financial Results

    ORLANDO, FL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. ("CODA" or the "Company") (NASDAQ:CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology and AI-enabled real-time subsea imaging and enhanced situational awareness for manned and autonomous platforms and advanced augmented diving technology, today reported its audited financial results for its fiscal year ended October 31, 2025 (FY2025). Annmarie Gayle, CODA's Chairman and CEO, commented: "I am pleased with our overall results of operations in FY2025, especially the increase in our consolidated net revenue, operating income, pre-tax income and earnings per share. Both our Core Business and the Def

    1/29/26 7:00:00 AM ET
    $CODA
    Industrial Machinery/Components
    Industrials

    $ACXP
    $ALPN
    $AUGX
    $BTBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Exagen Inc.

    SC 13G/A - EXAGEN INC. (0001274737) (Subject)

    12/12/24 5:00:54 PM ET
    $XGN
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Eyenovia Inc.

    SC 13D/A - EYENOVIA, INC. (0001682639) (Subject)

    12/4/24 4:12:20 PM ET
    $EYEN
    Biotechnology: Pharmaceutical Preparations
    Health Care